Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
3 More presentations in this session
Professor B. Rocca (Casamassima, IT)
Assistant Professor C. Koh (Singapore, SG)
Professor L. Jennings (Memphis, US)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
